{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T19:10:15Z","timestamp":1761419415603},"reference-count":25,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2020,8,7]]},"DOI":"10.1253\/circrep.cr-20-0056","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T22:05:27Z","timestamp":1593641127000},"page":"433-439","source":"Crossref","is-referenced-by-count":3,"title":["Sudden Cardiac Death-Relevant Events of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort\u3000\u2015 Results From the Kochi RYOMA Study \u2015"],"prefix":"10.1253","volume":"2","author":[{"given":"Toru","family":"Kubo","sequence":"first","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Ochi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asa","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Hirota","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohito","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohisa","family":"Hamashige","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chikamori Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhito","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kochi Health Sciences Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiaki","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Japanese Red Cross Kochi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanji","family":"Bando","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tosa Municipal Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Susaki Kuroshio Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Furuno","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kochi Prefectural Aki General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikazu","family":"Yabe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kochi Prefectural Hata Kenmin Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori L.","family":"Doi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"},{"name":"Department of Cardiology, Chikamori Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kitaoka","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Maron BJ. Clinical course and management of hypertrophic cardiomyopathy. <i>N Engl J Med<\/i> 2018; 379: 655\u2013668.","DOI":"10.1056\/NEJMra1710575"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: Clinical course and outcome in an unselected regional population. <i>J Am Coll Cardiol<\/i> 1995; 26: 1529\u20131536.","DOI":"10.1016\/0735-1097(95)00353-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. <i>JAMA<\/i> 1999; 281: 650\u2013655.","DOI":"10.1001\/jama.281.7.650"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kofflard MJM, Ten Cate FJ, van der Lee C, van Domberg RT. Hypertrophic cardiomyopathy in a large community-based population: Clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. <i>J Am Coll Cardiol<\/i> 2003; 41: 987\u2013993.","DOI":"10.1016\/S0735-1097(02)03004-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, et al. Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population. <i>Circulation<\/i> 2000; 102: 858\u2013864.","DOI":"10.1161\/01.CIR.102.8.858"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American College of Cardiology\/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. <i>Eur Heart J<\/i> 2003; 24: 1965\u20131991.","DOI":"10.1016\/S0195-668X(03)00479-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. <i>Circulation<\/i> 2011; 124: 2761\u20132796.","DOI":"10.1161\/CIR.0b013e318223e230"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). <i>Eur Heart J<\/i> 2014; 35: 2733\u20132779.","DOI":"10.1093\/eurheartj\/ehu284"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kubo T, Kitaoka H, Okawa M, Hirota T, Hayato K, Yamasaki N, et al. Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy: Results from Kochi RYOMA Study. <i>Circ J<\/i> 2009; 73: 1599\u20131605.","DOI":"10.1253\/circj.CJ-09-0140"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kubo T, Hirota T, Baba Y, Ochi Y, Takahashi A, Yamasaki N, et al. Patients\u2019 characteristics and clinical course of hypertrophic cardiomyopathy in a regional Japanese cohort: Results from Kochi RYOMA Study. <i>Circ J<\/i> 2018; 82: 824\u2013830.","DOI":"10.1253\/circj.CJ-17-0845"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with hypertrophic cardiomyopathy (JCS 2012): Digest version. <i>Circ J<\/i> 2016; 80: 753\u2013774.","DOI":"10.1253\/circj.CJ-66-0122"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Spirito P, Rapezzi C, Autore C, Bruzzi P, Bellone P, Ortolani P, et al. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. <i>Circulation<\/i> 1994; 90: 2743\u20132747.","DOI":"10.1161\/01.CIR.90.6.2743"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Lado M, McKenna WJ. Non-sustained ventricular tachycrdia in hypertrophic cardiomyopathy: An independent marker of sudden death risk in young patients. <i>J Am Coll Cardiol<\/i> 2003; 42: 873\u2013879.","DOI":"10.1016\/S0735-1097(03)00827-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. <i>J Am Coll Cardiol<\/i> 2005; 45: 697\u2013704.","DOI":"10.1016\/j.jacc.2004.11.043"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wang W, Lian Z, Rowin EJ, Maron BJ, Maron MS, Link MS. Prognostic implications of nonsustained ventricular tachycardia in high-risk patients with hypertrophic cardiomyopathy. <i>Arrhythm Electrophysiol<\/i> 2017; 10: e004604.","DOI":"10.1161\/CIRCEP.116.004604"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. <i>Circulation<\/i> 2006; 114: 216\u2013225.","DOI":"10.1161\/CIRCULATIONAHA.105.583500"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kawarai H, Kajimoto K, Manami Y, Hagiwara N, Kasanuki H. Risk of sudden death in end-stage hypertrophic cardiomyopathy. <i>J Card Fail<\/i> 2011; 17: 459\u2013464.","DOI":"10.1016\/j.cardfail.2011.01.015"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Goto D, Kinugawa S, Hamaguchi S, Sakakibara M, Tsuchihashi-Makaya M, Yokota T, et al. Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: Report from the registry data in Japan. <i>J Cardiol<\/i> 2013; 61: 65\u201370.","DOI":"10.1016\/j.jjcc.2012.08.010"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kubo T, Baba Y, Hirota T, Tanioka K, Yamasaki N, Doi YL, et al. Prognostic significance of no-dilated left ventricular size and mitral regurgitation in patients with dilated phase of hypertrophic cardiomyopathy. <i>Int Heart J<\/i> 2017; 58: 63\u201368.","DOI":"10.1536\/ihj.16-109"},{"key":"20","unstructured":"20. Tsusui H, Kitaoka H, Isobe M, Ide T, Ueda H, Ono M, et al. JCS 2018 guideline on diagnosis and treatment of cardiomyopathies (in Japanese). 2019. http:\/\/www.j-circ.or.jp\/guideline\/pdf\/JCS2018_tsutsui_kitaoka.pdf (accessed August 31, 2018)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kitaoka H, Kubo T, Okawa M, Hitomi N, Furuno T, Doi YL. Left ventricular remodeling of hypertrophic cardiomyopathy: Longitudinal observation in a rural community. <i>Circ J<\/i> 2006; 70: 1543\u20131549.","DOI":"10.1253\/circj.70.1543"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bogaert J, Olivotto I. MR imaging in hypertrophic cardiomyopathy: From magnet to bedside. <i>Radiology<\/i> 2014; 273: 329\u2013348.","DOI":"10.1148\/radiol.14131626"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nakagawa S, Okada A, Nishimura K, Hamatani Y, Amano M, Takahama H, et al. Validation of the 2014 European Society of Cardiology sudden cardiac death risk prediction model among various phenotypes in Japanese patients with hypertrophic cardiomyopathy. <i>Am J Cardiol<\/i> 2018; 122: 1939\u20131946.","DOI":"10.1016\/j.amjcard.2018.08.042"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. O\u2019Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. <i>J Am Coll Cardiol<\/i> 2010; 56: 867\u2013874.","DOI":"10.1016\/j.jacc.2010.05.010"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, et al. Prognositic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. <i>Circulation<\/i> 2014; 130: 484\u2013495.","DOI":"10.1161\/CIRCULATIONAHA.113.007094"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/2\/8\/2_CR-20-0056\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T03:25:39Z","timestamp":1596857139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/2\/8\/2_CR-20-0056\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-20-0056","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,7]]}}}